10x Genomics, Inc. Debt Securities, Available-for-sale, Realized Gain (Loss)
10x Genomics, Inc. (TXG) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2025-11-07
- 10x Genomics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-09-30 was $0.00.
- 10x Genomics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-06-30 was $0.00.
- 10x Genomics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-03-31 was $0.00.
- 10x Genomics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-09-30 was $0.00.
- 10x Genomics, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2022 was $0.00.
- 10x Genomics, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2021 was $0.00.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-13 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-15 |